Skip to main content
. Author manuscript; available in PMC: 2025 Apr 1.
Published in final edited form as: J Clin Periodontol. 2024 Jan 7;51(4):464–473. doi: 10.1111/jcpe.13940

Table 5.

WHIM Subject Data by Periodontal Diagnosis

WHIM Subjects Stage I/II Stage III/IV p-value
Age 25 (21 – 38) 40 (33.5 – 52.8) 0.0319
Gender (Male/Female) (number) 3/4 5/9 >0.9999
Ethnicity (Caucasian/Non-Caucasian) (number) 6/1 8/6 0.3371
   Hispanic 1 4
   Black 0 2
   Asian 0 0
Smoking (Former or Current/Never) (number) 0/7 3/11 0.5211
BMI 23 (21 – 27) 26 (20.8 – 29.3) 0.8411
White Blood Count (WBC) 1200 (960 – 7590) 1705 (1413 – 3190) 0.1969
Absolute Lymphocyte Count (ALC) 580 (350 – 820) 885 (685 – 1510) 0.0938
Absolute Monocyte Count (AMC) 140 (60 – 200) 135 (50 – 332.5) 0.8706
Absolute Neutrophil Count (ANC) 760 (330 – 900) 505 (307.5 – 1565) 0.9850
Trough ANC 140 (30 – 310) 125 (77.5 – 290) 0.5465
G-CSF Therapy (Past or Current/None) (number) 6/1 14/0 0.1588
Plerixafor Therapy (Past or Current/None) (number) 4/3 13/1 0.0877
IVIG Therapy (Past or Current/None) (number) 4/3 6/8 0.6594

Values given as median (interquartile range) unless otherwise indicated. Significant p-values are in bold.